Ghana Food and Drugs Authority (FDA) has approved the use R21/Matrix-MTM, a malaria vaccine developed by the University of Oxford and Serum Institute of India, beating Nigeria to deploy the innovative solution against the deadly disease.
Despite carrying the largest burden of the disease in the w
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```